Global Genome Editing Market Size, Status and Forecast 2020-2026

Genome editing, or genome engineering is a type of genetic engineering in which DNA is inserted, deleted, modified or replaced in the genome of a living organism. In 2018, the common methods for such editing use engineered nucleases, or "molecular scissors". These nucleases create site-specific double-strand breaks (DSBs) at desired locations in the genome. The induced double-strand breaks are repaired through nonhomologous end-joining (NHEJ) or homologous recombination (HR), resulting in targeted mutations.
The increasing application of genome engineering in treating chronic ailments and therapeutics will be one of the key factors fueling the growth of genome editing market during the next few years. With the continuous prevalence of infectious and chronic diseases such as hepatitis, tuberculosis, malaria, HIV/AIDS, and others, the application of genome editing in treating these ailments has increased considerably in the recent years. According to CDC, there were about 1.8 million new cases of HIV reported in 2016. Such a rapidly increasing number of HIV cases have led to the researchers to work on new gene-based therapies for reducing morbidity and mortality of HIV-infected patients. Consequently, the rise in prevalence of such ailments will impact the demand for novel therapies equipping several genome editing tools in the forthcoming years.

Market Analysis and Insights: Global Genome Editing Market
The global Genome Editing market size is projected to reach US$ 3621.7 million by 2026, from US$ 3291.6 million in 2020, at a CAGR of 9.3%% during 2021-2026.

Global Genome Editing Scope and Market Size
Genome Editing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Genome Editing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study

Genscript
Horizon Discovery Group
Lonza
Merck KGaA
Sangamo Therapeutics
Thermo Fisher Scientific
...

Market segment by Type, the product can be split into

CRISPR
TALEN
ZFN

Market segment by Application, split into

Cell Line Engineering
Animal Genetic Engineering
Plant Genetic Engineering

Market segment by Regions/Countries, this report covers

North America
Europe
China
Japan
Southeast Asia
India

Frequently Asked Questions